CN Energy Group, Inc. — Form 20-F Summary
Reporting period: Fiscal year ended September 30, 2023, with comparative audited results for 2022 and 2021. This is an annual report, not a standalone 2023 fourth-quarter filing. Filed February 15, 2024. Amounts below are U.S. dollars unless stated otherwise.
Business context
CN Energy is a British Virgin Islands holding company whose operations are primarily in China. It manufactures and sells wood-based activated carbon and produces biomass electricity as a byproduct. Activated carbon generated virtually all revenue in fiscal 2023. The company also acquired forestry assets in Yunnan in November 2022 and completed an internal corporate restructuring in December 2023.
Key financial metrics
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $57.9 million | $40.2 million |
| Gross profit / margin | $0.8 million / 1.36% | $3.6 million / 9.06% |
| Operating income (loss) | $(6.2) million | $0.5 million |
| Net income (loss) | $(5.6) million | $2.2 million |
| Operating cash flow | $(30.2) million | $(7.5) million |
| Cash at year-end | $0.2 million | $18.0 million |
| Bank loans | $5.2 million | $4.2 million |
| Convertible note, current | $2.0 million | — |
| Current assets / current liabilities | $72.4 million / $22.5 million | $74.2 million / $30.5 million |
Net working capital was approximately $49.9 million based on the balance-sheet totals. Current assets included $29.0 million of net accounts receivable and $39.0 million of net advances to suppliers. Cash and cash equivalents fell by $17.9 million during the year.
Changes versus the prior year
- Revenue rose 44%, principally as activated-carbon sales volume increased 39% to 40,251 tons; average selling price also rose about 4%.
- Cost of revenue grew 56%, faster than revenue. Activated-carbon unit cost increased 12%, while unit selling price rose 4%; gross margin consequently fell from 9.06% to 1.36%.
- The company moved from $2.2 million net income to a $5.6 million net loss. General and administrative expenses rose to $5.7 million from $2.1 million, including consulting, biological-asset depreciation, director compensation, and professional fees.
- Operating cash outflow worsened to $30.2 million, largely reflecting increases in supplier advances ($21.8 million) and receivables ($11.3 million). Management said approximately $29.5 million of the year-end receivables had been collected by the filing date.
- Activated-carbon output at the Tahe facility fell to 2,865 tons, about 37% of its stated annual capacity, from 6,594 tons in 2022. The company attributed the reduction to inadequate raw-material supply. Employees declined to 30 from 150.
Outlook, risks and unusual items
- Liquidity: Management believes current operations can meet daily working-capital needs over the next 12 months, but year-end cash was only $0.2 million and operating cash flow was substantially negative. The company may seek additional debt, equity, or credit facilities.
- Facility and environmental permit: Construction of the Manzhouli facility was suspended from August 2023; the company discontinued further investment after local wood-market changes undermined raw-material availability. Approximately $9.8 million had been spent, and $3.6 million of equipment prepayments remained at year-end, with delivery under negotiation. Separately, the Tahe pollutant-discharge license expired in 2023; related production was temporarily ceased pending renewal. The filing estimates renewal may take three to six months.
- Debt and financing: The $3.23 million Streeterville convertible note carried 7% interest and had $2.0 million principal outstanding at year-end. A November 2023 forbearance followed a redemption notice; the agreement imposed a 3.25% fee. The filing also identifies bank loans that became overdue after year-end, with extensions under negotiation. Several borrowings are guaranteed by directors or the controlling shareholder.
- Concentration and working-capital exposure: Three customers represented 36% of FY2023 sales; three customers represented 51% of year-end receivables. Two suppliers accounted for 26% of purchases, and five suppliers represented 70% of supplier advances. Recovery and collectability of the large receivable and supplier-advance balances are important uncertainties.
- Contingency: Subsidiaries faced an ordinary-course lawsuit with potential exposure of RMB8 million (about $1.1 million); the controlling shareholder committed to cover the potential obligation if mediation fails.
- Controls and governance: Management concluded disclosure controls and internal control over financial reporting were ineffective at September 30, 2023, citing insufficient U.S. GAAP/SEC reporting expertise and inadequate monitoring mechanisms. Management described remediation efforts; the auditor did not attest to internal-control effectiveness.
- Other investor risks: Operations are concentrated in China and subject to PRC regulatory, currency-conversion, and fund-remittance risks. The company reported no dividends and does not expect to pay them in the foreseeable future. A 1-for-30 share consolidation became effective January 18, 2024; Nasdaq subsequently notified the company that it had regained bid-price compliance.
Important facts to verify
- Reconcile the filing’s accounting-basis checkboxes, which appear to indicate IFRS, with the audited financial statements’ stated preparation under U.S. GAAP.
- Confirm the status and subsequent collection of the $29.0 million receivable balance and the realization or refund of $39.0 million in supplier advances.
- Check current status of the expired Tahe discharge permit, production restart, and any required environmental compliance spending.
- Confirm the Manzhouli project’s final disposition, recovery of equipment prepayments and deposits, and any impairment or loss recognized after year-end.
- Verify repayment, extension, or conversion status of the Streeterville note and the bank loans reported as overdue after year-end.
- Reconcile reported figures: the cash-flow discussion gives FY2023 financing cash flow as $13.3 million, while the cash-flow statement shows $13.4 million; the filing also contains differing current-liability totals in its narrative and balance sheet.
- Assess progress on remediation of the material control weaknesses and review the dilutive potential of outstanding warrants and the 2023 share-incentive plan.